BII
CKPT

Bainco International Investors’s Checkpoint Therapeutics CKPT Stock Holding History

Bainco International Investors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,135
Closed -$61K – 82
2019
Q1 		$61K Sell
2,135
-4,903
-70% -$157K 0.01% 82
2018
Q4 		$128K Buy
7,038
+5,300
+305% +$126K 0.02% 91
2018
Q3 		$62K Sell
1,738
-7,558
-81% -$264K 0.01% 97
2018
Q2 		$277K Buy
+9,296
New +$321K 0.04% 86

Other funds holding CKPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Bainco International Investors's CKPT Position: Q2 2019 in Review

Bainco International Investors sold out of Checkpoint Therapeutics (CKPT) in Q2 2019, closing a stake of 2,135 shares — an estimated $61K sold.

Bainco International Investors first reported a position in CKPT in Q2 2018 and held it in 4 quarters. The position peaked at $277K in Q2 2018. 40 funds tracked by Wall St. Rank hold CKPT as of Q2 2019.

  • Bainco International Investors reported no remaining Checkpoint Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Bainco International Investors sold 2,135 Checkpoint Therapeutics shares in Q2 2019, an estimated $61K.
  • Bainco International Investors first reported a position in Checkpoint Therapeutics in Q2 2018 and held it in 4 quarters.
  • Bainco International Investors's Checkpoint Therapeutics position peaked at $277K in Q2 2018.
  • 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2019.

Based on Bainco International Investors's 13F filing for Q2 2019, filed 22 Jul 2019.